Anthony Wallace; Anthony DeFino , 2025-04-26 19:58:00
April 26, 2025
2 min watch
LOS ANGELES — In this Healio Video Perspective from the ASCRS meeting, Anthony Wallace, of Bausch + Lomb, provides further details on the return to market of enVista IOLs.
As Healio previously reported, Bausch + Lomb voluntarily recalled the enVista platform due to reports of toxic anterior segment syndrome in patients implanted with the IOLs in the U.S.
“I am pleased to report that we’ve identified the root cause, we’ve made some adjustments to our processes and inspections, and we have returned to full production,” Wallace said.
Sources/Disclosures
Collapse
Healio Interviews
Disclosures:
Wallace reports being vice president and general manager, U.S. surgical, Bausch + Lomb.
